Abstract
Introduction: Isolated limb perfusion (ILP) is a treatment option for patients with melanoma in-transit metastases of the extremities. The procedure is mainly used to keep loco-regional disease in control and thereby increase the patients’ health-related quality of life (HRQOL). However, limited knowledge exists about the baseline HRQOL levels in patients with in-transit metastasis, and what factors that mostly affect this.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
